Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03612960 · ClinicalTrials.gov registry record · NA
Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT03612960 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 34 participants.
The verdict
NCT03612960, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The overall goal of this study is to determine if switching to very low nicotine content cigarettes changes the function of brain circuitry involved in incentive salience and executive control among dependent smokers.
Interventions
- DRUG Very low nicotine content cigarettes
- DRUG Normal nicotine content cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2020-02-20 |
| Est. Completion | 2023-06-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03612960
The ClinicalTrials.gov registry entry for NCT03612960 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Very low nicotine content cigarettes is the first listed.
NCT03612960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03612960 about?
NCT03612960 is a clinical study titled "Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes". The overall goal of this study is to determine if switching to very low nicotine content cigarettes changes the function of brain circuitry involved in incentive salience and executive control among dependent smokers.
What is the current status of trial NCT03612960?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2020-02-20. Estimated completion is 2023-06-23.
What interventions are being tested in trial NCT03612960?
The interventions under investigation include: Very low nicotine content cigarettes (DRUG), Normal nicotine content cigarettes (DRUG).
Who is sponsoring clinical trial NCT03612960?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.